National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 05/06/2008



General Information About Mycosis Fungoides and the Sézary Syndrome






Stages of Mycosis Fungoides and the Sézary Syndrome






Recurrent Mycosis Fungoides and the Sézary Syndrome






Treatment Option Overview






Treatment Options by Stage






Treatment Options for Recurrent Mycosis Fungoides and the Sézary Syndrome






To Learn More About Mycosis Fungoides and the Sézary Syndrome






Get More Information From NCI






Changes to This Summary (05/06/2008)






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Recurrent Mycosis Fungoides and the Sézary Syndrome

Recurrent mycosis fungoides and the Sézary syndrome are cancers that have recurred (come back) after they have been treated. The cancer may come back in the skin or in other parts of the body.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov